Corporate Profile
Corporate Profile
Search
Our Responsibility
Human Health Our Responsibility
Partnering
We are convinced that diversity and exchange in science give birth to innovations. For this reason, partnerships are an important component of our innovation strategy.
Innovation through Collaboration
Pharmaceutical manufacturers and healthcare professionals regularly interact to learn from each other and improve patient care.
Poultry
Poultry
Unleashing Innovation at Boehringer Ingelheim
Join us at our upcoming seminar and networking event where we'll share our unique approach to fostering innovation and supporting startups. We're excited to introduce you to Research Beyond Borders, our approach to open science: opnMe.com
history movie
Learn more about Boehringer Ingelheim's history of more than 130 years, from the beginning in 1885 to today. We share documents and insights from our history, our business areas and our research and development activities across the decades.
Human Health Innovation
Boehringer Ingelheim focuses its research activities on disease areas with a high unmet medical need.
Science & Innovation
We improve patients' health and quality of life. This has been the central goal of the research-based pharmaceutical company Boehringer Ingelheim for 130 years.
Drug discovery Boehringer Ingelheim
Every day, scientists at Boehringer Ingelheim embark on a journey. It is a journey that can take up to 15 years and requires significant investment. Only a tiny proportion of these journeys are successful.
Women in STEM: Passion for science to achieve more sustainable healthcare solutions
Women in STEM: Passion for science to achieve more sustainable healthcare solutions
Boehringer Ingelheim Office Hours 2024: Shaping the Future of Innovation in Europe
Boehringer Ingelheim is actively supporting the next generation of innovators.
Venture Fund searching for groundbreaking trends
The Boehringer Ingelheim Venture Fund acquires minority stakes in biotech start-ups, and even supports the majority before and during their founding.
Boehringer Ingelheim Office Hours
Boehringer Ingelheim Office Hours
Making sustainable medicines through eco-design
Our goal is to minimize the environmental footprint of our medicines through integration of eco-design and green chemistry across the entire lifecycle
Fact & Figures Boehringer Ingelheim RCV
Facts and figures speak a clear language. Only economic success enables us to implement our corporate vision.
Small Molecule Drug Discovery
Boehringer Ingelheim scientists continue to expand the horizons of what small molecule drugs can achieve.
Computational Biology & Digital Sciences
At Boehringer Ingelheim, we are investing into the power of computational biology and data sciences to accelerate the journey from scientific discoveries to breakthrough therapies.
75 Years Boehringer Ingelheim in Austria
75 Years Boehringer Ingelheim in Austria
Improving the current state of schizophrenia care
A closer look at the status of the schizophrenia care landscape, an often misunderstood mental health condition
Making a difference in clinical trials: The impact of engagement
We are partnering with patients, caregivers and trial site staff to design and conduct our clinical trials, to provide a better experience for all.
Who we are
The Boehringer Ingelheim Regional Center Vienna (RCV for short) bears business responsibility for more than 30 countries in Central and Eastern Europe and Central Asia.
The global $1 trillion mental health problem needs more funding
Nearly one billion people around the world live with a mental health condition, yet an estimated 70% don’t have access to the help they need.
Immune cell directed therapies
Boehringer Ingelheim is committed to transforming cancer care, investigating therapies that target cancer cells and boost the immune system for the benefit of patients.
Our Commitment
Humanity faces great challenges. We believe that we can always do more - for ourselves and for future generations.